Appendix A, Table 2. COVID-19 Treatment Guidelines Panel Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics
Last Updated: October 9, 2020
Reporting Period: October 1, 2019, to September 30, 2020
Panel Member | Financial Disclosure | |
---|---|---|
Company | Relationship | |
Judith Aberg, MD | Atea Pharmaceuticals | Research Support |
Emergent BioSolutions | Research Support | |
Gilead Sciences | Research Support | |
Pfizer | Research Support | |
Regeneron | Research Support | |
Adaora Adimora, MD, MPH | Gilead Sciences | Research Support |
Merck & Co. | Advisory Board, Consultant | |
Jason Baker, MD, MS | Gilead Science | Research Support |
Humanigen | Research Support | |
Lisa Baumann Kreuziger, MD, MS | 3M | Stockholder, Spouse Is Employee |
Quercegen Pharmaceuticals | Advisory Board for Nonapproved Medications | |
Versiti | Employee | |
Roger Bedimo, MD, MS | Gilead Sciences | Advisory Board |
Merck & Co. | Advisory Board | |
ViiV Healthcare | Advisory Board, Research Support | |
Pamela S. Belperio, PharmD | None | N/A |
Laura Bosque Ortiz, BS | None | N/A |
John T. Brooks, MD | None | N/A |
Timothy Burgess, MD | None | N/A |
Danielle M. Campbell, MPH | ViiV Healthcare | Summit Attendee |
Stephen V. Cantrill, MD | None | N/A |
Ann C. Collier, MD | None | N/A |
Craig Coopersmith, MD | None | N/A |
Page Crew, PharmD, MPH | None | N/A |
Eric Daar, MD | Genentech | Consultant |
Gilead Sciences | Consultant, Research Support | |
Merck & Co. | Consultant, Research Support | |
ViiV Healthcare | Research Support | |
Richard T. Davey, Jr., MD | None | N/A |
Susan L. Davis, PharmD | Merck & Co. | Honoraria |
Laurie K. Doepel, BA | None | N/A |
Amy L. Dzierba, PharmD | None | N/A |
Robert W. Eisinger, PhD | None | N/A |
Laura Evans, MD, MSc | None | N/A |
Joseph Francis, MD, MPH | None | N/A |
John J. Gallagher, DNP, RN | Medtronic | Consultant |
Rajesh Gandhi, MD | None | N/A |
David V. Glidden, PhD | Gilead Sciences | Consultant |
Merck & Co. | Advisory Board | |
Birgit Grund, PhD | None | N/A |
Roy M. Gulick, MD, MPH | None | N/A |
Alison Han, MD | None | N/A |
Erica J. Hardy, MD, MMSc | None | N/A |
Carly Harrison | AstraZeneca | Advisory Board |
Aurinia Pharmaceuticals | Advisory Board, Stockholder | |
Elizabeth S. Higgs, MD, DTM&H, MIA | None | N/A |
Carl Hinkson, MSRC | None | N/A |
Brenna L. Hughes, MD, MSc | Merck & Co. | Advisory Board |
Steven Johnson, MD | ViiV Healthcare | Advisory Board |
Marla J. Keller, MD | None | N/A |
Arthur Kim, MD | None | N/A |
Safia Kuriakose, PharmD | None | N/A |
H. Clifford Lane, MD | None | N/A |
Jeffrey L. Lennox, MD |
None |
N/A |
Andrea M. Lerner, MD, MS |
None |
N/A |
Mitchell M. Levy, MD |
Inotrem | Research Support |
Gregory Martin, MD, MSc | Beckman Coulter | Consultant |
Genentech | Data and Safety Monitoring Board Chair/Member | |
Regeneron | Consultant | |
Henry Masur, MD | None | N/A |
Susanna Naggie, MD, MHS | AbbVie | Research Support |
Gilead Sciences | Research Support | |
Vir Biotechnology | Advisory Board, Stockholder | |
Martha C. Nason, PhD |
Bristol-Myers Squibb Company | Stockholder |
Medtronic | Stockholder | |
Alice K. Pau, PharmD |
None | N/A |
Andrew T. Pavia, MD | GlaxoSmithKline | Consultant (related to influenza) |
Nitin Seam, MD | None | N/A |
Virginia Sheikh, MD, MHS | None | N/A |
Steven Q. Simpson, MD | None | N/A |
Kanal Singh, MD, MPH | None | N/A |
Susan Swindells, MBBS | ViiV Healthcare | Research Support |
Pablo Tebas, MD | Inovio Pharmaceuticals | Research Support |
Phyllis Tien, MD, MSc | Merck & Co. | Research Support |
Timothy M. Uyeki, MD, MPH | None | N/A |
Alpana A. Waghmare, MD | AlloVir | Research Support |
Ansun BioPharma | Research Support | |
Kyorin Pharmaceutical Co. | Advisory Board | |
Robert Walker, MD | None |
N/A |
Kevin C. Wilson, MD | None | N/A |
Jinoos Yazdany, MD, MPH | AstraZeneca | Consultant, Research Support |
Eli Lilly and Company | Consultant | |
Pfizer | Consultant |